dr. reinhard dummer on toxicities with binimetinib in metastatic melanoma
Published 8 years ago • 323 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
31:31
reinhard dummer: melanoma
-
2:29
dr. dummer on nemo trial for nras-mutant melanoma
-
1:14
dr. dummer on driver mutations and next steps in melanoma
-
0:57
professor dr. reinhard dummer on melanoma research and smr 2015
-
1:02
dr. flaherty on the tolerability of encorafenib/binimetinib in melanoma
-
21:02
clinical results, patient cases and future developments i: melanoma – reinhard dummer
-
8:47
braf/mek inhibitors in metastatic melanoma
-
1:17
dr. dummer on combi-ad trial results in braf-mutant melanoma
-
4:42
dr. al stroberg: surviving long after a melanoma diagnosis thanks to immunotherapy
-
36:04
melanoma and brain metastases
-
31:44
melanoma & immunotherapy: ask dr. michael atkins
-
5:59
targeting nras mutations in metastatic melanoma
-
1:37
binimetinib vs. dacarbazine in nras-mutant melanoma
-
6:56
emerging immunotherapy combinations for melanoma
-
1:32
dr. liebman on toxicities of braf inhibitors in melanoma
-
4:27
looking to the future of melanoma
-
3:05
targeting therapies improve progression-free survival in melanoma
-
5:31
neoadjuvant therapy for melanoma
-
1:27
combi-ad: implications for melanoma patients
-
4:32
overall toxicities with immunotherapy in melanoma
-
4:33
overall toxicities with immunotherapy in melanoma
-
1:53
a new era for target therapy in metastatic melanoma